Literature DB >> 21566890

Relationship between e-cadherin expression and lymph-node metastasis in human esophageal cancer.

M Miyata1, H Shiozaki, K Iihara, K Shimaya, H Oka, T Kadowaki, M Inoue, S Tamura, M Takeichi, T Mori.   

Abstract

Expression of E-cadherin in esophageal carcinoma was studied immunohistochemically in 65 patients using an anti-human E-cadherin monoclonal antibody (HECD-1). In normal esophageal epithelium, E-cadherin was strongly expressed on cell-cell boundaries. On the contrary, a reduced E-cadherin expression (Rd-type) was frequently observed in cancer tissues (56/65, 88%). The frequency of Rd-type was much higher in cases with deeper invasion (48/52, 92%) than that in cases with superficial invasion (8/13, 62%) (p<0.05). Concerning lymph node metastasis, the frequency of Rd-type in the metastatic tumor group (47/49, 96%) was significantly higher than that in the non-metastatic tumor group (9/16, 56%) (p<0.01). These results suggest that E-cadherin might play a key role in the progression of carcinogenesis and that the reduction of E-cadherin expression is associated with malignant potential such as invasion and metastasis in human esophageal cancer.

Entities:  

Year:  1994        PMID: 21566890

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  2 in total

1.  Expression and potential role of E-cadherin in pancreatic carcinoma.

Authors:  R J Weinel; K Neumann; O Kisker; A Rosendahl
Journal:  Int J Pancreatol       Date:  1996-02

2.  Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis.

Authors:  David S Liu; Sanne J M Hoefnagel; Oliver M Fisher; Kausilia K Krishnadath; Karen G Montgomery; Rita A Busuttil; Andrew J Colebatch; Matthew Read; Cuong P Duong; Wayne A Phillips; Nicholas J Clemons
Journal:  Oncotarget       Date:  2016-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.